Related Experiment Video
Updated: Aug 15, 2026

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
Society for Maternal-Fetal Medicine Position Statement: Decriminalization of substance use disorder in pregnancy
Abstract:
The Society for Maternal-Fetal Medicine supports evidence-based screening for and treatment of substance use disorder in pregnancy. The Society for Maternal-Fetal Medicine strongly opposes any policies or practices that are aimed toward or result in the punishment or criminalization of substance use in pregnancy, including punitive legislation, routine biologic toxicology testing, and mandated reporting to the family regulation system (e.g., child protective services, child welfare system). The Society for Maternal-Fetal Medicine acknowledges and aims to eliminate the racial and ethnic disparities in which people of color are disproportionately subject to substance use screening and testing, reporting to the family regulation system, and the effects of punitive legislation.
Related Concept Videos
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Drug Abuse and Addiction: Pharmacological Phenomena
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Drug Control Governance: Regulatory Bodies and Their Impact
Drug Dependence
Diagnostic and Statistical Manual of Mental Disorders (DSM)
